Foretinib induces G2/M cell cycle arrest, apoptosis, and invasion in human glioblastoma cells through c-MET inhibition-Reference-Cited by-同舟云学术

Foretinib induces G2/M cell cycle arrest, apoptosis, and invasion in human glioblastoma cells through c-MET inhibition

Published:2021-03-10 Issue:6 Volume:87 Page:827-842
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Gortany Narges K.,Panahi Ghodratollah,Ghafari Homanaz,Shekari Maryam,Ghazi-Khansari Mahmoud^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00280-021-04242-0.pdf

Reference69 articles.

1. Haas-Kogan D, Shalev N, Wong M, Mills G, Yount G, Stokoe D (1998) Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr Biol 8(21):1195-S1191

2. Thakkar JP, Dolecek TA, Horbinski C, Ostrom QT, Lightner DD, Barnholtz-Sloan JS, Villano JL (2014) Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Prev Biomarkers 23(8):2199

3. Tamimi AF, Juweid M (2017) Epidemiology and outcome of glioblastoma. In: Glioblastoma. Codon Publications

4. Omuro A, DeAngelis LM (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA 310(17):1842–1850

5. Pearson JR, Regad T (2017) Targeting cellular pathways in glioblastoma multiforme. Signal Transduct Target Ther 2:17040

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The combination therapy using tyrosine kinase receptors inhibitors and repurposed drugs to target patient-derived glioblastoma stem cells;Biomedicine & Pharmacotherapy;2024-07

2. Foretinib, a c-MET receptor tyrosine kinase inhibitor, tackles multidrug resistance in cancer cells by inhibiting ABCB1 and ABCG2 transporters;Toxicology and Applied Pharmacology;2024-03

3. Inhibition of Aurora Kinase Induces Endogenous Retroelements to Induce a Type I/III IFN Response via RIG-I;Cancer Research Communications;2024-02-26

4. Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment;International Journal of Molecular Sciences;2024-01-23

5. Acrylates-based hydrophilic co-polymeric nanobeads as nanocarriers for imaging agents;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2023-10